Craig Gedye
- Oncology top 2%
- Molecular Biology top 10%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 5%
- Co-authors
- Anthony J. KettleChristine C. WinterbournLaurie AillesIan D. DavisMaries van den BroekJacob LevineKarīna SiliņaCarola H. Ries
- Topics
- Renal cell carcinoma treatment (22 papers)Cancer Immunotherapy and Biomarkers (22 papers)Cancer Genomics and Diagnostics (18 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Craig Gedye
97 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 1.2k
- Molecular Biology 1.0k
- Immunology 953
- Pulmonary and Respiratory Medicine 852
- Cancer Research 450
Countries citing papers authored by Craig Gedye
This map shows the geographic impact of Craig Gedye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Gedye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Gedye more than expected).
Fields of papers citing papers by Craig Gedye
This network shows the impact of papers produced by Craig Gedye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Gedye. The network helps show where Craig Gedye may publish in the future.
Co-authorship network of co-authors of Craig Gedye
This figure shows the co-authorship network connecting the top 25 collaborators of Craig Gedye. A scholar is included among the top collaborators of Craig Gedye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Gedye. Craig Gedye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 6 | |
| 13 | 18 | |
| 14 | 27 | |
| 15 | ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer | 1 |
| 16 | 19 | |
| 17 | 27 | |
| 18 | 18 | |
| 19 | 44 | |
| 20 | 152 |
About Craig Gedye
Craig Gedye is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 101 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Cancer Genomics and Diagnostics (18 papers). The work is most often cited by research in Immunology (953 citations), Oncology (1.2k citations) and Cancer Research (450 citations). Craig Gedye has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Anthony J. Kettle, Christine C. Winterbourn, Laurie Ailles, Ian D. Davis, Maries van den Broek, Jacob Levine, Karīna Siliņa, Carola H. Ries, Michael Stadler and Dana Pe’er. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.